The HRB CRF-C provides a Study Feasibility service and the necessary supports to optimise study start-up activities.
Study feasibility is a process through which a clinical trial sponsor (or representative e.g. Clinical Research Organisations) identifies potential investigator sites and evaluates if they are suitable to conduct the clinical trial. Feasibility requests may arise from several sources, including:
- HRB CRCI Feasibility service
- From a clinician who has been directly contacted by Pharma
- Directly from a CRO/Pharma company
- From a national or international thematic research network
The HRB CRF-C Study Feasibility service is coordinated through a dedicated feasibility coordinator who navigates local systems and engages with potential investigators, leading to efficient and timely decisions regarding the feasibility of all the hospitals affiliated with the HRB CRF-C as sites for a clinical trial or clinical investigation.
The HRB Clinical Research Facility at UCC is also part of the HRB CRCI National Study Feasibility Programme. This national programme connects academic and industry sponsors with potential investigators. HRB CRCI act as the channel through which study feasibility assessments can be distributed and completed efficiently.
Dedicated CRCI staff based in each CRF support Investigators with the rapid & accurate completion of the feasibility assessment and timely delivery of study start-up and first patient first visit (FPFV).
Please contact Maeve Kelsey, Site Management and Operations ManagerENQUIRE